bovine leukosis : are we up to the challenge
DESCRIPTION
Bovine Leukosis : Are We Up To The Challenge. Greg Keefe DVM MSc MBA Omid Nekouei DVM. Introduction. Terminology Enzootic Bovine Leukosis (EBL) = “the disease” Bovine Leukemia Virus (BLV) = “the virus” Spread Blood or other sources of “blood cells” - PowerPoint PPT PresentationTRANSCRIPT
Introduction• Terminology
– Enzootic Bovine Leukosis (EBL) = “the disease”
– Bovine Leukemia Virus (BLV) = “the virus”• Spread
– Blood or other sources of “blood cells”– Not a free virus – needs to be in cells
• Any blood contact – Needles, dehorners, bloody trimming knives, rectal sleeves
• Also possible - colostrum, milk, reproductive procedures, in-utero (before birth) exposure
2
Introduction• Progression of Leukosis
1. Infection and development of permanent carrier state
2. Increase in circulating white blood cells – about 30% of animals develop this stage
3. Tumors – called “lymphsarcoma” in approximately 5% of animals• Superficial lymph nodes• Heart• Stomach/intestine• Spinal canal • Reproductive tract
Introduction• Diagnosis
– Mainly blood/milk antibody tests (ELISA) – Also postmortem and with a test for the virus
RNA (genetic material)• Control/eradication
– The cornerstone in all programs is preventing blood cell movement• Needles, gloves, instruments, colostrum, insects???
– Test & slaughter/segregation/biosecurity measures
– Herd conditions/goals dictate program
4
Importance• BLV can be is economically significant
– premature culling or death as a result of lymphosarcoma
– The condemnation of carcasses at slaughter– Lower production & reproductive
performance– Indirect losses: from export restrictions
• Whole countries have eradicated– UK, Denmark, Netherlands, France…..
• The prevalence in North America is increasing
5
Historic prevalence of BLV in Canada by province
7
PEI (89)
PEI Ont Que NS NB Sask Alb Man 0
20
40
60
80
100
120Animal level Herd level
1998-2003
5.5%
63%
49%
16.6%
Current BLV project• Sponsored by 3 regional boards
and AAFC (ADAPT/CAAP program)• Objectives:
– Test ability of bulk tank milk ELISA to predict prevalence
– Establish prevalence at herd level and estimate cow level
• Pave the way for herd categorization/risk assessment/ management plan similar to AJDI
General design: sampling rounds for all Maritimes dairy herds
BTM 1 BTM 2 BTM 3
BTM 4 in 90
selected herds plus all individ
ual milk
samples
11
Stratified random sampling of 90 based on
BT ELISA values (5)
641 634 628
Stratified random sampling
90 herdsNB (30)NS (30)PEI (30)
12
Based on values of BT samples from the 5
groups
Only Valacta herds
<5, 5-40, 40-55, 55-70, >70
Results from 85 herds• Manufacturers recommended cutoff of <5 = Neg• 6 herds with BT value<5 (BTM neg) in fact had a
single positive low ELISA titre animal • All negative herds were correctly classified
13
IndividualBT
- + Total
- (<5) 12 6 18+ (≥5) 0 67 67
Total 12 73 85
Relative * Sn: 91.8%* Sp: 100%
At herd-level
Prediction of within-herd prevalence by BT-values (modeling)
14
Correlation ~ 85%
With
in –h
erd
prev
alen
ce
BT ELISA values
0.1
.2.3
.4.5
.6.7
.8.9
1W
ithin
-her
d P
reva
lenc
e
0 10 20 30 40 50 60 70 80 90 100 110 120 130BT copp
Overall herd prevalence• 623 herds tested 3X – 67 are <5 = negative (11%)• Can estimate within herd prevalence for the positive herds
16
020
4060
80Fr
eque
ncy
0 20 40 60 80 100mean 3 copp
A
B
C
D E BTM ELISA score and cow prevalence estimateA - < 5 = negativeB - 5 to 40 = 10%C- 40-55 = 20%D - 55-70 = 40%E - >70 = 70%
BLV take-home thoughts• BTM testing worked very well to determine
status/predict level – unfortunately........
• Prevalence of BLV infection at herd and cow levels in the Maritimes has been increased over time very high now
• We need a practical control plan for BLV
• Hence the title - Are We Up To The Challenge
17
Atlantic Healthy HerdsJohne’s Control
AJDI
Calf Mgmt and colostrum assessment
Internal parasite treatment model
BLV Control and Risk Management
BVD eradication and biosecurity
Web port - Data collection, delivery
benchmarkingLameness Mgmt.
and Benchmarking
Atlantic Healthy Herds• Cost of these diseases is $10
M/year in Atlantic Canada• Support from the 4 regional
boards• Seeking matching program
funding• Phased rollout in beginning in
2014